# Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

**Authors:** Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, Siow-Wey Hee, Chi-Fon Chang, Hsin-Yung Yen, Yi-An Chen, Yet-Ran Chen, Ya-Wen Chou, Fu-An Li, Yi-Yu Ke, Shih-Yi Chen, Ming-Shiu Hung, Alfur Fu-Hsin Hung, Jing-Yong Huang, Chu-Hsuan Chiu, Shih-Yao Lin, Sheue-Fang Shih, Chih-Neng Hsu, Juey-Jen Hwang, Teng-Kuang Yeh, Ting-Jen Rachel Cheng, Karen Chia-Wen Liao, Daniel Laio, Shu-Wha Lin, Tzu-Yu Chen, Chun-Mei Hu, Ulla Vogel, Daniel Saar, Birthe B Kragelund, Lun Kelvin Tsou, Yu-Hua Tseng, Lee-Ming Chuang

PMC · DOI: 10.1038/s44321-025-00228-0 · EMBO Molecular Medicine · 2025-04-03

## Full-text entities

- **Genes:** PTGR2 (prostaglandin reductase 2) [NCBI Gene 145482] {aka HEL-S-298, PGR2, ZADH1}
- **Diseases:** obesity (MESH:D009765), diabetes (MESH:D003920)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12081718/full.md

---
Source: https://tomesphere.com/paper/PMC12081718